Presbyterian Health Foundation Research Grants Program - 2022
Deadline: various -please see the table below
Description: This grant program funds multiple types of projects and has enabled the progression of pioneering concepts to research studies, the establishment of renowned clinicians and basic scientists transdisciplinary teams unifying a broad range of expertise and skills, the development of extremely talented junior faculty, the provision of infrastructure support for faculty to continue ground-breaking research, and more.
Click here to learn more about the 2022 opportunities.
If you have any questions, please email ORA4PHF@ouhsc.edu.
Link to Full Announcement: https://research.ouhsc.edu/Resources/PHF-Funding-2022
Grant Type
|
Deadline
|
Bridge
|
April 1, 2022
|
OUHSC GeroScience T32 is accepting applications for Post-Doctoral Fellows & Graduate Students to Appoint May 1st, 2022
Purpose: Goal of the GeroScience T32 is to offer training and mentorship to young investigators, both Graduate Students and Post-Doctoral Fellows interested in aging research and assist them in securing independent funding. Current trainees must reapply.
Eligibility:
- Must be a US citizen or permanent resident (green card holder)
- Project must be designed to address aging and age-related disease.
- Students must have successfully completed the PH.D. qualifying examination
Application Submission Deadline: APRIL 1, 2022
Link to Full Announcement: Please refer to the attached flyer.
Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).
- A global pharmaceutical company (requested anonymity) is seeking research related to generation of T cells, both alpha beta and gamma delta, from induced pluripotent stem cells (iPSC’s) for therapeutic uses. Out of scope: NK cell focused research (other than intermediate NKT’s). Submission entails a 1-pg non-confidential summary of technology (deadline 4/8)
- One.Five, a biomaterials discovery company is seeking scientists and research groups with experience in paper modifications and coatings at lab and pilot scale. Out of scope: corrugated solutions, petroleum based solutions and oxo-degradable coatings. Submission entails a 1-pg non-confidential summary of technology (deadline 4/18)
Investigator Initiated Trials Funding Committee (IITFC), Clinical Trials Office-Protocol Support Unit
Description: Grant proposals are being accepted from Stephenson Cancer Center Providers for their investigator-initiated clinical trials (IITs) or translational work for the amount of up to $100,000 for IITs and up to $25,000 for translation research. All applications should be submitted to the Protocol Support Unit at SCC-IIT-Office@ouhsc.edu and should adhere to the Submission Checklist provided with this notice.
Application Submission Deadline: April 4, 2022
Link to Full Announcement: Please refer to the attached flyer
College of Medicine Alumni Association (COMAA) Research Program
Description: Proposals are being accepted from full time faculty of the College of Medicine for grants to be awarded from the College of Medicine Alumni Association with proceeds generated from the Evening of Excellence dinner fund. COMAA awards are intended to be an important resource for funding basic and clinical research projects of new and early stage investigators in the College of Medicine. The guidelines are included with this notice.
NOTE: All applications MUST be routed through the Office of Research Administration (ORA) and include the NIH face page (https://grants.nih.gov/grants/funding/phs398/fp1.pdf) signed by the appropriate ORA institutional official.
Application Submission Deadline: April 15, 2022
Link to Full Announcement: Please refer to the attached flyers.
- Pre-Application Webinar for NOT-CA-22-056, Administrative Supplements to Support Germline Genome-wide Genotyping and Sequencing of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data
(NOT-CA-22-064)
- Notice of Change to Update Other Clinical Trial-related Attachments in PAR-21-241 NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
(NOT-AT-22-017)
- Notice of Termination of RFA-DA-22-033, "Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)"
(NOT-DA-22-059)
- Notice of Change to Assistance Listing Number(s) for PA-21-151 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"
(NOT-ES-22-008)
- Notice of NICHD Participation in PAR-22-000 "Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)"
(NOT-HD-22-012)
- Notice of Application Submission and Due Date Changes for RFA-HL-23-010, "Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)"
(NOT-HL-22-015)
- Notice of Application Due Date Changes for RFA-HL-23-011,"Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)"
(NOT-HL-22-016)
- Notice of Application Due Date Changes for RFA-HL-23-012, "Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)"
(NOT-HL-22-017)
- Application Due Date Changes for RFA-HL-23-013, "Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)"
(NOT-HL-22-018)
- Application Due Date Changes for RFA-HL-23-014, "Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33)"
(NOT-HL-22-019)
- Notice of Change in Eligibility to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)
(NOT-TR-22-024)
- Notice of Change in Award Information to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)
(NOT-TR-22-025)
- Notice of Change in Funding Opportunity Description and Application and Submission Information to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)
(NOT-TR-22-026)
- Notice of Intent to Publish a Funding Opportunity Announcement for Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)
(NOT-DK-22-018)
- Notice of Intent to Publish a Funding Opportunity Announcement for Reproductive Scientist Development Program (RSDP) (K12 Clinical Trial Not Allowed)
(NOT-HD-22-006)
- Notice of Intent to Publish a Funding Opportunity Announcement for Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early Stage Development (UG3/UH3 Clinical Trial Not Allowed)
(NOT-NS-22-086)
- Notice of Intent to Publish a Funding Opportunity Announcement for Impact of the Microbiome Gut-Brain Axis on ADRD (R01 Clinical Trial Not Allowed)
(NOT-NS-22-088)
- Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Stimulate or Strengthen Global Cancer Health Disparities Research
(NOT-CA-22-057)
- Notice of Special Interest (NOSI): Technological Innovations for Advancing Clinical SPECT Imaging
(NOT-EB-22-006)
- Notice of Special Interest (NOSI): Recruitment Innovation Center (RIC) Topic Area for Limited Competition: Clinical and Translational Science Award Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
(NOT-TR-22-020)
- Notice of Special Interest (NOSI) Trial Innovation Center (TIC) Topic Area for Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
(NOT-TR-22-021)
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
- Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)
(PAR-22-076)
Application Receipt Date(s): Multiple dates, see announcement.
- Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
(PAR-22-126)
Application Receipt Date(s): Multiple dates, see announcement.
- Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
(PAR-22-127)
Application Receipt Date(s): Multiple dates, see announcement.
- Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)
(RFA-CA-22-017)
Application Receipt Date(s): Not Applicable
- Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
(RFA-CA-22-021)
Application Receipt Date(s): Multiple dates, see announcement.
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
(RFA-CA-22-022)
Application Receipt Date(s): Multiple dates, see announcement.
- Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
(RFA-CA-22-023)
Application Receipt Date(s): Multiple dates, see announcement.
- Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
(RFA-CA-22-024)
Application Receipt Date(s): Multiple dates, see announcement.
- Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
(RFA-DA-23-014)
Application Receipt Date(s): August 11, 2022
- Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional)
(RFA-MD-22-008)
Application Receipt Date(s): November 13, 2022
- Understanding Suicide Risk and Protective Factors among Black Youth (R01 Clinical Trial Not Allowed)
(RFA-MH-22-140)
Application Receipt Date(s): June 20, 2023
- Understanding Suicide Risk and Protective Factors among Black Youth (R21 Clinical Trial Not Allowed)
(RFA-MH-22-141)
Application Receipt Date(s): June 20, 2023
- BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
(RFA-MH-22-220)
Application Receipt Date(s): June 07, 2024
Pandemic Antiviral Discovery (PAD) Henipavirus – Request for proposals 2022
Description: This RFP will support projects that seek to elucidate the molecular determinants of henipavirus replication, pathogenesis and transmission for the purpose of developing therapeutic discovery programs targeting virus and/or host-specific targets important for virus replication. Projects can be of both novel and exploratory nature and of later-stage validation/developmental nature.
Deadline: 5 May 2022
Link to Full Announcement: https://padinitiative.com/henipavirus-request-for-proposals-2022/
DoD FY22 Ovarian Cancer Research Program (OCRP)
- Pilot Award (PA)
- Proteogenomics Research Award (PGRA)
- Ovarian Cancer Academy Award - Early-Career Investigator (OCA)
- Investigator-Initiated Research Award (IIRA)
Pre-Application (Preproposal): May 2, 2022
Application: August 5, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/ocrp
DoD FY22 Orthotics and Prosthetics Outcomes Research Program (OPORP)
- Clinical Research Award (CRA)
- Clinical Trial Award (CTA)
Pre-Application (Letter of Intent): May 4, 2022
Application: June 1, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/oporp
DoD FY22 Epilepsy Research Program (ERP)
- Idea Development Award (IDA)
- Research Partnership Award (RPA)
- Virtual Post- Traumatic Epilepsy Research Center Leadership Award
(Virtual-P-TERC-L)
- Virtual Post- Traumatic Epilepsy Research Center Faculty Award
(Virtual-P-TERC-F)
Pre-Application (Letter of Intent): May 19, 2022
Application: June 23, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/erp
DoD FY22 Breast Cancer Research Program (BCRP)
- Breakthrough Award Levels 1 and 2 (BTA12)
- Era of Hope Scholar Award (EOHSA)
Pre-Application (Letter of Intent): May 3, 2022
Application: May 17, 2022
Confidential Letters of Recommendation Submission Deadline: May 20, 2022
- Breakthrough Award Level 3 (BTA3)
- Breakthrough Award Level 4 (BTA4)
- Innovator Award (INNOV)
- Transformative Breast Cancer Consortium Award (TBCCA)
Pre-Application (Preproposal): April 28, 2022
Invited Application: July 27, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/bcrp
DoD FY22 Amyotrophic Lateral Sclerosis Research Program (ALSRP)
- Pilot Clinical Trial Award
- Clinical Biomarker Development Award
- Therapeutic Development Award
- Therapeutic Idea Award
Pre-Application (Preproposal): April 29, 2022
Invitation to Submit an Application: June 2022
Application: July 28, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/alsrp
DoD FY22 Lung Cancer Research Program (LCRP)
- Career Development Award (CDA)
- Concept Award (CA)
Pre-Application (Letter of Intent): May 3, 2022
Letter of Intent is required.
Application: May 17, 2022
- Clinical Translational Research Partnership Award (CTRPA)
Pre-Application (Letter of Intent): July 13, 2022
Letter of Intent is required.
Application: July 27, 2022
- Idea Development Award (IDA)
- Investigator-Initiated Translational Research Award (IITRA)
Pre-Application (Preproposal): May 4, 2022
Preproposal is required; application submission is by invitation only.
Application: July 27, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/lcrp
DOD FY22 Peer Reviewed Medical Research Program (PRMRP)
- Clinical Trial Award (CTA)
- Focused Program Award (FPA)
Pre-Application (Preproposal): May 6, 2022
Application: August 12, 2022
Pre-Application (Letter of Intent): April 22, 2022
Application: May 20, 2022
- Investigator-Initiated Research Award (IIRA)
- Technology/Therapeutic Development Award (TTDA)
Pre-Application (Letter of Intent): April 29, 2022
Application: May 27, 2022
Link to Full Announcement: https://cdmrp.army.mil/funding/prmrp
Summer Research Training for Junior Faculty from Diverse Backgrounds
Description: The National Heart, Lung, and Blood Institute seeks pre-applications for its Programs to Increase Diversity Among Individuals Engaged in Health Related Research (PRIDE) initiative. PRIDE offers hands-on, mentored research lab experiences, small project awards for pilot research, and grant writing courses for junior faculty and transitioning post-doctoral candidates from diverse backgrounds. The goal is to increase diversity in the biomedical research workforce while enabling early career investigators to become competitive independent scientists.
Chosen applicants will have their training expenses fully covered for two consecutive summers. Training takes place at nine NHLBI-funded sites across the country, and each program is centered on a different area of heart, lung, blood, and sleep disorders research:
Pre-Applications Due: March 31, 2022
Link to Full Announcement: https://pridecc.wustl.edu/
HHS/CDC (Forecasted) Building Mathematical Modeling Workforce Capacity to Support Infectious Disease and Healthcare Research
Description: The purpose of this notice of funding opportunity is to support pre-doctoral fellows’ innovative research to develop and apply computational tools and mathematical methods for modeling the spread of pathogens in healthcare settings (e.g., SARS-CoV-2, healthcare-associated infections [HAIs], antimicrobial resistant organisms [AROs]). This NOFO is intended to increase the number of junior modeling professionals that are trained and experienced in modeling transmission of pathogens in healthcare settings and to contribute to generalizable scientific knowledge through dissemination (e.g., pre-prints, peer-reviewed studies, scientific presentations). The application should be written by the PI/mentor who may or may not name specific pre-doctoral student(s) to conduct the research at the time of application submission.
Estimated Application Due Date: May 4, 2022
Link to Full Announcement: https://www.grants.gov/web/grants/view-opportunity.html?oppId=337897
Robert Wood Johnson Foundation Funding Opportunities
The Robert Wood Johnson Foundation funds a wide array of research and initiatives to help address some of America’s most pressing health challenges.
The Interdisciplinary Research Leaders program seeks teams of researchers and community members committed to working together improve health equity by dismantling structural racism.
Application Due Date: Wed, 4 May 2022
Evidence for Action prioritizes research to evaluate specific interventions that have the potential to contribute to dismantling and counteracting the harms of structural and systemic racism and improving health, well-being, and equity outcomes.
Application Due Date: Proposals will be accepted throughout the year on a rolling admission
Pioneering Ideas: Exploring the Future to Build a Culture of Health welcomes proposals that are primed to influence health equity in the future.
Application Due Date: Proposals will be accepted throughout the year on a rolling admission
Link to Full Announcement: https://www.rwjf.org/en/how-we-work/grants-explorer/funding-opportunities.html
The International Center for Responsible Gaming (ICRG) 2022 Grants Program
Description: The ICRG awards grants on a competitive basis for a variety of research activities exploring the etiology, prevention and treatment of gambling disorder and the development and evaluation of responsible gambling strategies.
Large Grant: Up to $75,000/per year in direct costs for 2 years
Deadline for Letters of Intent: April 1, 2022
Application Deadline: June 30, 2022
Seed Grant: Up to $30,000/per year in direct costs for one year
Application Deadline: May 2, 2022
Link to Full Announcement: https://www.icrg.org/research-center/apply-icrg-funding
Southwest Center for Occupational and Environmental Health Pilot Projects Research Training Program
Description: The goal of the Pilot Projects Research Training Program is to enhance Southwest Center for Occupational and Environmental Health (SWCOEH) regional outreach efforts in research training and to foster stronger inter-institutional ties in occupational health research within Public Health Region 6 (PHR 6) (Arkansas, Louisiana, New Mexico, Oklahoma and Texas). The objective of this program is to provide a support mechanism for pilot research projects initiated by:
- Research Trainee Awards: Graduate doctoral students or postdoctoral fellows in an occupational health and safety-related discipline.
- Junior Investigator Awards: New investigators with research interests in the general area of occupational health and safety. Junior investigators are defined as faculty who have not served as PI on any Public Health Service (PHS)-supported research grants other than a R03, R15, R21, K01, K08, or K12.
- New Researcher Awards: Researcher or Faculty in areas other than occupational health research who wish to apply their expertise to an occupational safety and health issue.
Letters of Intent Due: March 15, 2022
Full proposals Due: April 15, 2022
Link to Full Announcement: https://sph.uth.edu/research/centers/swcoeh/pilot-projects/
NIH technology accelerator challenge for maternal health
Description: The National Institute of Biomedical Imaging and Bioengineering (NIBIB), with the support of its partners, is offering up to $1,000,000 in cash prizes for innovative diagnostic technologies to help improve maternal health around the world.
The NIH Technology Accelerator Challenge for Maternal Health (NTAC: Maternal Health) seeks to spur and reward the development of prototypes for low-cost, point-of-care molecular, cellular, and/or metabolic sensing and diagnostic technologies to guide rapid clinical decision-making, improve patient outcomes, and ultimately prevent maternal morbidity and mortality.
To win NTAC: Maternal Health, participants must: (1) Submit their design for a point-of-care diagnostic test or platform technology with initial feasibility data or references addressing at least two of the four priority conditions listed below affecting maternal health during antenatal and intrapartum periods; and (2) Submit a robust description of the proposed path for translation and further development of the diagnostic technology for use in global health settings. Additionally, diagnostics should be fully integrated digital health platforms. The four priority conditions and specific examples are as follows:
- Infection: viral, bacterial, or parasitic infections; sepsis; post-procedural infections
- Hypertensive disease: pre-eclampsia; eclampsia
- Hemorrhage: acute anemia; iron deficiency anemia; coagulopathy
- Placental issues: angiogenic or other markers of placental disruption
Proposals Due: April 1, 2022
Link to Full Announcement: https://venturewell.org/ntac/
The International Foundation for Ethical Research (IFER) – 2022-2023 GRADUATE FELLOWSHIPS FOR ALTERNATIVES TO THE USE OF ANIMALS IN SCIENCE
Description: IFER Graduate Fellowships are one-year grants for projects that support the development, acceptance and implementation of innovative scientific methodologies that advance science and refine, reduce or replace the use of animals in research, testing or education. Grants of $12,500 are typically awarded and are renewable annually for up to three years, depending on student progress and availability of funds. IFER recognizes the value in directing financial resources away from animal models and toward the development of human-relevant, non-animal models, as such resources pay higher dividends for human health when used for human-relevant research.
Pre-proposals Due: April 30, 2022
Link to Full Announcement: More information on the IFER Graduate Fellowship program, including eligibility requirements, submission guidelines, and a link to the online application can be found on the IFER website at www.ifer.org/fellowships.php.
Melanoma Research Alliance (MRA) Dermatology Fellowship & Junior Faculty Awards
Description: The aim of this training program is to drive greater interest and focus on melanoma in dermatologic clinical practice and research related to the prevention, detection, diagnosis, and staging of melanoma.
- MRA Dermatology Fellows Award – Supports dermatology residents, fellows, or post-docs in a dermatology program with research, and/or demonstration and pilot programs focused on melanoma prevention or improving early detection, diagnosis, or prognosis.
- MRA Dermatology Junior Faculty/Clinical Instructor Award - Supports new dermatology
faculty (clinical instructors or new assistant professors) working in research on melanoma
prevention or improving early detection, diagnosis, or prognosis.
Proposals Due: April 20, 2022
Link to Full Announcement: https://www.curemelanoma.org/research/request-for-proposals/dermatology-fellows-award